Vol 15, Issue 2

ACUTE LOW-DOSE CAPSIATE SUPPLEMENTATION IMPROVES UPPER BODY RESISTANCE EXERCISE PERFORMANCE IN TRAINED MEN: A RANDOMIZED, CROSSOVER AND DOUBLE-BLIND STUDY

Authors

Helton Pereira dos Santos Nunes de MouraFederal University of Piaui
Jason Michael CholewaUniversity of Lynchburg
Ralf JaegerIncrenovo LLC
Eduardo Zapaterra CamposFederal University of Penambuco
Bruno Viana RosaFederal University of Piaui
Flavio Antônio de Sousa NunesFederal University of Piaui
Clara Clara Andressa de Araújo BarrosFederal University of Piaui
Priscila Almeida Queiroz RossiFederal University of Piaui
Jose Gerosa-NetoUniversity Center of Maringá
Nelo E. ZanchiFederal University of Maranhão
Fabricio Eduardo RossiFederal University of Piauí (UFPI)
International Journal of Exercise Science 15(2): 1007-1018, 2022.
DOI: 10.70252/YNEM9216

Abstract

International Journal of Exercise Science 15(2): 1007-1018, 2022. Objectives: The purpose of this study was to compare the effects of two acute doses of Capsiate (CAP; 6 vs. 12 mg) on upper body resistance exercise performance in trained men. Methods: Using a randomized, crossover and double-blind design, 20 resistance-trained males were supplemented with low-dose CAP (6 mg), high-dose CAP (12 mg) or placebo 45 minutes before exercise. Subjects performed 4 sets of bench press with repetitions to failure at 70% 1 repetition maximum (1RM) and 2 minutes of rest between each set. The ratings of perceived exertion (RPE) and blood lactate were analyzed at baseline and after exercise. Results: Total weight lifted was greater in the low CAP (2,454.6 ± 448.6 kg) compared to placebo (2,354.7 ± 458.6 kg, p = 0.039) and high CAP (2,309.3 ± 428.1 kg, p = 0.001). There was no significant difference between conditions for RPE (p = 0.155) and blood lactate (p = 0.434). Conclusion: In summary, 6 mg CAP increased total weight lifted and repetitions to failure on bench press exercise in trained men, while 12 mg did not present any effect.

Recommended Citation